Home
Conditions
Ependymoma

Clinical trial condition

Ependymoma

Explore clinical trials studying Ependymoma. Study availability and eligibility vary by location and protocol.

170 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Ependymoma trial results

Completed

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

NCT01026493

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations: Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

Cancer Research Center of Hawaii Honolulu, Hawaii, United States

Queen's Cancer Institute at Queen's Medical Center Honolulu, Hawaii, United States

View all 17 locations

View Trial Details

Completed

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

NCT00499798

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +32 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

NCT00498927

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma

NCT01498783

Conditions: Central Nervous System Malignancies, Ependymoma, Glioma, +7 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Study of Tissue Samples From Patients With Glioma or Other Brain Tumors

NCT00967200

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +28 more
Locations: CHU Montpellier Montpellier, France

Clinique Gui de Chauliac Montpellier, France

View Trial Details

Completed

Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma

NCT00387933

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

NCT01119599

Conditions: Acoustic Schwannoma, Adult Anaplastic (Malignant) Meningioma, Adult Anaplastic Astrocytoma, +69 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Completed

Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2

NCT01082926

Conditions: Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Meningioma, +33 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

CC-5013 in Treating Patients With Recurrent Glioma

NCT00036894

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +22 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

NCT00005796

Conditions: Astrocytoma, Bone Marrow Suppression, Brain Diseases, +25 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Ependymoma

Ependymoma trial results

Related conditions